About the Company
omeros is a seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $OMER News
OMER Aug 2024 3.000 put
SEATTLE, February 20, 2024--Omeros Corporation (Nasdaq: OMER) today announced the upcoming presentation of a report detailing narsoplimab treatment in nine adult patients with hematopoietic stem cell ...
Verrica Pharma gains as FDA lists Ycanth in Orange Book
Verrica Pharmaceuticals (VRCA) receives FDA's NCE status for Ycanth, as FDA lists the antiviral in its Orange Book with five ...
S&P 500 Posts a Record High on Optimism the Fed Can Achieve a Soft Landing
Detailed price information for Valero Energy Corp (VLO-N) from The Globe and Mail including charting and trades.
Sleeping Giants: 3 Picks With Massive Upside by Mid-Decade
Hidden gems often remain undiscovered within the labyrinth of the stock market. Three stocks with massive upside stand out ...
Loading the latest forecasts...